Merck Will Share Formula for Its Covid Pill With Poor Countriesnews2021-10-27T21:07:22+00:00October 27th, 2021|The New York Times|
Gates Foundation Pledges $120 Million to Help Get Merck Covid Pills to Poor Countriesnews2021-10-20T19:15:15+00:00October 20th, 2021|The New York Times|
Will New Covid Treatments Be as Elusive for Poor Countries as Vaccines?news2021-10-17T21:15:06+00:00October 17th, 2021|The New York Times|
Merck Asks F.D.A. for Emergency Approval of Covid Pillnews2021-10-12T04:25:38+00:00October 12th, 2021|The New York Times|
Asia-Pacific Countries Rush to Buy Merck Covid Pillnews2021-10-07T12:59:12+00:00October 7th, 2021|The New York Times|
La píldora contra la covid: así es como funcionanews2021-10-04T17:14:20+00:00October 4th, 2021|The New York Times|
Fauci: Americans Should Get Vaccinated Even if Merck’s Covid Pill Cuts Deathsnews2021-10-04T00:09:58+00:00October 4th, 2021|The New York Times|
Merck Says Its Antiviral Pill Is Effective Against Covidnews2021-10-02T01:28:38+00:00October 2nd, 2021|The New York Times|
Merck’s Covid Treatment Pill: What to Know About Molnupiravirnews2021-10-01T20:06:31+00:00October 1st, 2021|The New York Times|
Ivermectin Won’t Treat Covid-19, but Demand Is High Anywaynews2021-09-04T20:11:24+00:00September 4th, 2021|The New York Times|